PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Actinobacillus Infections D000189 4 associated lipids
Adenocarcinoma D000230 166 associated lipids
Alzheimer Disease D000544 76 associated lipids
Anal Gland Neoplasms D000694 1 associated lipids
Anaphylaxis D000707 35 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Ascariasis D001196 3 associated lipids
Asthma D001249 52 associated lipids
Astrocytoma D001254 15 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Blister D001768 16 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Body Weight D001835 333 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Bronchial Spasm D001986 18 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Reddy RC and Standiford TJ Nrf2 and PPAR{gamma}: PPARtnering against oxidant-induced lung injury. 2010 Am. J. Respir. Crit. Care Med. pmid:20634499
Suzuki R and Freed AN Heparin inhibits hyperventilation-induced late-phase hyperreactivity in dogs. 2002 Am. J. Respir. Crit. Care Med. pmid:11779726
Krawiec ME et al. Persistent wheezing in very young children is associated with lower respiratory inflammation. 2001 Am. J. Respir. Crit. Care Med. pmid:11371398
Kowalski ML et al. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. 2000 Am. J. Respir. Crit. Care Med. pmid:10673176
Cho HY et al. Nrf2-regulated PPAR{gamma} expression is critical to protection against acute lung injury in mice. 2010 Am. J. Respir. Crit. Care Med. pmid:20224069
Hanks BC et al. Evaluation of anti-inflammatory and chondroprotective effects of peroxisome proliferator-activated receptor gamma agonists in cartilage and synovial explants from dogs. 2010 Am. J. Vet. Res. pmid:20919899
Beasley R et al. Cholinergic-mediated bronchoconstriction induced by prostaglandin D2, its initial metabolite 9 alpha,11 beta-PGF2, and PGF2 alpha in asthma. 1987 Am. Rev. Respir. Dis. pmid:2960256
Liu MC et al. Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. 1990 Am. Rev. Respir. Dis. pmid:2368958
Ingenito EP et al. Bronchoalveolar lavage cell and mediator responses to hyperpnea-induced bronchoconstriction in the guinea pig. 1990 Am. Rev. Respir. Dis. pmid:2339838
Naclerio RM et al. Mediator release after nasal airway challenge with allergen. 1983 Am. Rev. Respir. Dis. pmid:6354022
Cohan VL et al. Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin. 1989 Am. Rev. Respir. Dis. pmid:2478059
Picado C et al. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. 1992 Am. Rev. Respir. Dis. pmid:1309968
Wang D et al. Aminophylline reduces air-flow-induced constriction in the canine lung periphery. 1988 Am. Rev. Respir. Dis. pmid:3422143
Schleimer RP et al. Characterization of inflammatory mediator release from purified human lung mast cells. 1986 Am. Rev. Respir. Dis. pmid:3485946
Gray PR et al. The role of cyclooxygenase products in the acute airway obstruction and airway hyperreactivity of ponies with heaves. 1989 Am. Rev. Respir. Dis. pmid:2502051
Eggleston PA et al. Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells. 1990 Am. Rev. Respir. Dis. pmid:1691604
Jongejan RC et al. Effects of inflammatory mediators on the responsiveness of isolated human airways to methacholine. 1990 Am. Rev. Respir. Dis. pmid:2240835
Holgate ST Contribution of inflammatory mediators to the immediate asthmatic reaction. 1987 Am. Rev. Respir. Dis. pmid:3473955
Fuller RW et al. Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. 1986 Am. Rev. Respir. Dis. pmid:3511806
Gundel RH et al. Antigen-induced mediator release in primates. 1991 Am. Rev. Respir. Dis. pmid:1648317
Wang D et al. Terbutaline acts at multiple sites to inhibit bronchoconstriction induced by dry air in canine peripheral airways. 1992 Am. Rev. Respir. Dis. pmid:1595994
Broide DH et al. Airway levels of mast cell-derived mediators in exercise-induced asthma. 1990 Am. Rev. Respir. Dis. pmid:1689974
Kleeberger SR et al. The role of mediators in the response of the canine peripheral lung to 1 ppm ozone. 1988 Am. Rev. Respir. Dis. pmid:2829670
Fernández PL [Stress and inflammatory bowell disease (I.B.D). Therapeutic strategies]. 2006 An R Acad Nac Med (Madr) pmid:17172222
Koyama J et al. Simultaneous determination of histamine and prostaglandin D2 using an LC-ESI-MS/MS method with positive/negative ion-switching ionization modes: application to the study of anti-allergic flavonoids on the degranulation of KU812 cells. 2011 Anal Bioanal Chem pmid:21725829
Hirano A et al. Arachidonic acid-induced channel- and carrier-type ion transport across planar bilayer lipid membranes. 2003 Anal Sci pmid:12608744
Chen Q et al. A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist. 2004 Anal. Biochem. pmid:15556564
Zorrilla S et al. Selective binding of the fluorescent dye 1-anilinonaphthalene-8-sulfonic acid to peroxisome proliferator-activated receptor gamma allows ligand identification and characterization. 2010 Anal. Biochem. pmid:20025845
Cao H et al. An improved LC-MS/MS method for the quantification of prostaglandins E(2) and D(2) production in biological fluids. 2008 Anal. Biochem. pmid:17976507
Welter H et al. Partial loss of contractile marker proteins in human testicular peritubular cells in infertility patients. 2013 Andrology pmid:23413143
Araki M et al. Isoflurane modulates phorbol myristate acetate-, prostaglandin D2-, and prostaglandin E2-induced alterations in hepatic flow and metabolism in the perfused liver in fasted rats. 1994 Anesth. Analg. pmid:7639362
Stellato C et al. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release. 1992 Anesthesiology pmid:1280014
Kashani IA et al. Effects of prostaglandins on the pulmonary vascular bed of newborn rats with chronic hypoxia. 1986 Angiology pmid:3511774
Cichocka-Jarosz E et al. Impact of Hymenoptera venom allergy and the effects of specific venom immunotherapy on mast cell metabolites in sensitized children. 2014 Ann Agric Environ Med pmid:24959779
Campbell AM et al. Conjunctival provocation tests with codeine phosphate. Effect of disodium cromoglycate. 1993 Ann Allergy pmid:7687104
Naclerio RM Effects of antihistamines on inflammatory mediators. 1993 Ann Allergy pmid:7690526
Campbell AM et al. In vitro activation of bronchoalveolar lavage cells by house dust mite allergens. 1992 Ann Allergy pmid:1371209
Wasserman SI Basic mechanisms in asthma. 1988 Ann Allergy pmid:3163472
Small P et al. Effects of intensity of early response to allergen on the late phase of both the nose and skin. 1994 Ann Allergy pmid:8092561
Orfan N et al. Systemic cold urticaria in a five-year-old boy. 1991 Ann Allergy pmid:1867452
Marone G et al. Mechanisms of activation of human mast cells and basophils by general anesthetic drugs. 1993 Ann Fr Anesth Reanim pmid:7690200
Fujishima H et al. Chemotactic responses of peripheral blood eosinophils to prostaglandin D2 in atopic keratoconjunctivitis. 2013 Ann. Allergy Asthma Immunol. pmid:23886231
Small P and Barrett D Evaluation of dust and dust mite nasal provocation. 1995 Ann. Allergy Asthma Immunol. pmid:8603280
Rank MA et al. Systemic reactions to allergen immunotherapy: a role for measuring a PGD2 metabolite? 2013 Ann. Allergy Asthma Immunol. pmid:23244662
Chiba T et al. The opposing role of two prostaglandin D2 receptors, DP and CRTH2, in human eosinophil migration. 2011 Ann. Allergy Asthma Immunol. pmid:21624751
Leynadier F [Mast cells and basophils in asthma]. 1989 Ann. Biol. Clin. (Paris) pmid:2675683
Liu JJ et al. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro. 2007 Ann. Hematol. pmid:17089125
Polosa R et al. [Mast cell mediator release after endobronchial challenge with adenosine 5'-monophosphate in asthmatic subjects]. 1994 Apr-Jun Ann. Ital. Med. Int. pmid:7522500
Barrett KE Effect of histamine and other mast cell mediators on T84 epithelial cells. 1992 Ann. N. Y. Acad. Sci. pmid:1456653
Kim EH et al. Upregulation of VEGF by 15-deoxy-Delta12,14-prostaglandin J2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cells. 2006 Ann. N. Y. Acad. Sci. pmid:17384282